Austin-based health technology company Everlywell has raised $175 million to expand its digital health offerings and its workforce.
Everlywell was founded by Dallas native Julia Cheek in 2015, and the company moved to Austin in 2016.
Everlywell focuses on home health care diagnostics, including at-home tests for food sensitivity, allergies, thyroid issues, hormones and vitamins. The company also has received authorization for an at-home test kit for COVID-19.
New investors in the financing round include funds and accounts managed by BlackRock, the Chernin Group, Foresite Capital, Greenspring Associates, Lux Capital, Morningside Ventures and Portfolia, as well as existing investors Goodwater Capital, Highland Capital Partners and Next Coast Ventures.
This investment brings the total capital raised by the company to more than $250 million.
“The pandemic has shed light on the challenges of lab testing for Americans, from unknown costs to confusion and inconvenience,” Cheek said. “We’ve been empowering people with